Results 21 to 30 of about 107,551,550 (224)
HTLV-1+ subject and uninfected volunteer samples used.
, 2023 HTLV-1+ subject and uninfected volunteer samples used.
David S. Rueda (7879094) +3 more
core +1 more source
Making Visible HTLV Infection in a Non-endemic Area of Argentina
Frontiers in Medicine, 2022 In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered ...
Federico R. Simioli +7 more
doaj +1 more source
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Frontiers in Microbiology, 2012 The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world, with clusters of high endemicity located often nearby areas where the ...
Antoine eGessain +5 more
doaj +1 more source
HTLV-1 prevalence according to age for 386 female and 334 male community residents.
, 2021 HTLV-1 infection was confirmed for 218 participants, using HTLV-1 western blots (WB) and/or HTLV-1 PCR (WB positive/PCR positive, 209; indeterminate WB/PCR positive, 8; tested by dried blood spot, PCR positive, 1).
Antoine Gessain (31917) +7 more
core +1 more source
No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms [PDF]
, 2007 Background The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of the simian T-cell lymphotropic ...
Hummel, Michael +9 more
core +1 more source
Journal of Clinical Pathology, 2000 Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of ...
openaire +2 more sources
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
Frontiers in Microbiology, 2012 Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis in small subsets of HTLV-1-carriers.
Mari eKannagi +4 more
doaj +1 more source
HTLV-1 prevalence by age and gender in seven remote central Australian communities, 2014–18.
, 2021 HTLV-1 prevalence by age and gender in seven remote central Australian communities, 2014–18.
Antoine Gessain (31917) +7 more
core +1 more source
PLoS Neglected Tropical Diseases, 2023 BackgroundHuman T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM/TSP) with a poor prognosis.
Akiko Kowada
doaj +1 more source
HTLV-1 and HIV/HTLV-1 prevalence distribution by sex and age class.
, 2022 The figure shows the overall prevalence of infection by age group and the prevalence of infection by sex: A) In the HIV-1/HTLV-1 coinfected population; B) In the general population at the same place.
Jeanne Sica (686072) +10 more
core +1 more source